Baird Financial Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Baird Financial Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,930	Closed	-$436K	–	1602
2020 Q1	$436K	Buy	6,930 +520	+8%	+$46.7K	﹤0.01%	1101
2019 Q4	$794K	Sell	6,410 -287	-4%	-$25.7K	﹤0.01%	1031
2019 Q3	$444K	Buy	6,697 +3,410	+104%	+$229K	﹤0.01%	1207
2019 Q2	$262K	Buy	3,287 +110	+3%	+$9.85K	﹤0.01%	1374
2019 Q1	$355K	Buy	+3,177	New	+$347K	﹤0.01%	1103
2015 Q4	–	Sell	-5,614	Closed	-$931K	–	1291
2015 Q3	$931K	Buy	5,614 +97	+2%	+$21.3K	0.01%	723
2015 Q2	$1.33M	Buy	+5,517	New	+$1.47M	0.01%	657

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baird Financial Group's ICPT Position: Q2 2020 in Review

Baird Financial Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 6,930 shares — an estimated $436K sold.

Baird Financial Group first reported a position in ICPT in Q2 2015 and held it in 7 quarters. The position peaked at $1.33M in Q2 2015. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

Baird Financial Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Baird Financial Group sold 6,930 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $436K.
Baird Financial Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
Baird Financial Group's Intercept Pharmaceuticals, Inc. position peaked at $1.33M in Q2 2015.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Baird Financial Group's 13F filing for Q2 2020, filed 14 Aug 2020.